New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Vyome Holdings, Inc.

HIND

Healthcare Biotechnology

Vyome Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $319,700.00, up 24.4% from fiscal 2024.

Revenue
+67.6%
EPS
n/m
Free cash flow
n/m

Quarter to September 2026, against a year earlier

1.20 0.25 −17.24%
Market cap
$10.2M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
4/9
ROIC
0.00%
Net debt / EBITDA
0.5×
Payout ratio
—

Ratios over time Q4 FY25 to Q3 FY26

Returns on capital

ROIC was 0.00% in Q3 FY26, the highest of these four quarters.

ROEROIC
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
ROE3263.0%−235.8%−172.1%−71.8%
ROIC0.0%0.0%0.0%0.0%

Debt

Net debt is 6.49× a year’s EBITDA. Debt is 0.05× equity, against 0.07× in Q4 FY25.

Debt / equityNet debt / EBITDA
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Debt / equity0.1×0.0×0.0×0.1×
Net debt / EBITDA3.5×7.8×9.2×6.5×

Per share, from Q4 FY25

Since Q4 FY25, per share: revenue has fallen 59.9%; book value has grown 45.9%.

RevenueBook value
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue1.0×0.4×0.3×0.4×
Book value1.0×1.9×1.6×1.5×
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
63.32 94.13 116.26 88.42
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(13.32) (10.02) (16.70) (21.58)
P/B ratio
5.38 1.79 2.06 2.07
Price to Tangible BV
5.87 1.86 2.16 2.17
EV/Sales
48.50 36.57 55.50 45.26
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(4.14) (1.12) (1.29) (1.55)
EV/FCF
(4.14) (1.12) (1.29) (1.55)
Quick Ratio
1.82 4.10 4.23 3.37
Current Ratio
1.99 4.27 4.37 3.68
Net Debt/EBITDA
3.50 7.80 9.17 6.49
Debt/Assets
3.77% 0.00% 0.00% 4.00%
Debt/Equity
0.07 0.00 0.00 0.05
Asset Turnover
0.08 0.02 0.01 0.02
Operating CF/Net income
1.24 1.49 1.32 0.71
Capex/Depreciation
0.00 0.00 0.00 0.00
Interest Coverage
(136.88) (403.54) (261.39) (352.10)
Research and Development Expense of Revenue
1,033.61% 2,108.86% 1,876.67% 706.55%
Selling, General and Administrative Expense of Revenue
2,721.86% 1,511.39% 1,351.48% 1,095.52%
Intangible Assets out of Total Assets
0.05 0.03 0.03 0.04
Share Based Compensation of Revenue
281.42% 112.97% 40.74% 303.28%
Graham Net Nets
0.13 0.49 0.42 0.41
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(44,674.97%) (36,064.10%) (166.43%) (30.61%)
Free Cash Flow Yield
(18.51%) (34.63%) (36.97%) (33.12%)
Revenue per Share
0.01 0.00 0.00 0.01
Operating CF per Share
(0.26) (0.21) (0.13) (0.09)
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.26) (0.21) (0.13) (0.09)
Cash per Share
0.85 1.31 1.12 0.99
Shareholders Equity per Share
0.64 1.20 1.04 0.93
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.64 1.20 1.04 0.93
Free Cash Flow
(1.52) (1.44) (0.90) (0.63)
Working Capital
2.70 7.02 6.29 5.53
Net Current Asset Value
2.70 7.02 6.29 5.53
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Payables
1.13 1.40 1.21 1.47
Average Assets
3.94 8.33 9.10 7.83
Average Common Equity
(0.31) 4.64 6.57 5.23

Fold the line items

Columns are period end dates · fundamentals updated Nov 18, 2026